top of page
Tudorza Pressair is an anticholinergic medication indicated for the treatment of a lung condition calledchronic obstructive pulmonary disease (COPD). Fact Table Formula C26H30BrNO4S2 License US DailyMed, US FDA Bioavailability Less than 5% Legal status Rx-only Chemical Name Aclidinium Elimination half-life 2 - 3 hours Dosage (Strength) (322mcg) 400mcg (60 doses/inhaler) Pregnancy Consult Doctor Brands Tudorza Pressair Protein binding 87% PubChem CID 11519741 MedlinePlus a613001 ChEBI 65344 ATC code R03BB05 DrugBank DB08897 KEGG D08837 Routes of administration Inhalation

Tudorza Pressair (Aclidinium)

  • Tudorza Pressair is in the form of an inhalation powder contained in an inhaler that delivers 400 mcg of aclidinium bromide per actuation. Once you are prescribed and buy Tudorza Pressair, the directions are to inhale one puff twice daily.
bottom of page